glutamic acid has been researched along with Cranial Nerve II Diseases in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 8 (57.14) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, Y; Liu, H; Zhang, R; Zhuang, D | 1 |
| Bollati, M; de Rosa, M; Drnovšek-Olup, B; Fakin, A; Gornik, A; Hawlina, M; Hočevar, A; Jaklič, H; Maver, A; Peterlin, B; Pfeifer, V; Pižem, J; Potrč, M; Teran, N; Vogelnik, K; Volk, M | 1 |
| London, A; Schwartz, M | 1 |
| Ishikawa, M; Izumi, Y; Yoshitomi, T; Zorumski, CF | 1 |
| Collignon-Robe, NJ; Haufroid, Y | 1 |
| Chun, T; Hare, WA; Lai, RK; Ruiz, G; Ton, H; Wheeler, L; WoldeMussie, E | 1 |
| Case, GL; Dahl, DB; Gabelt, BT; Hernandez, MR; Kaufman, PL; May, CA; Sherwood, RW; Wamsley, S | 1 |
| Domercq, M; Etxebarria, E; Matute, C; Pérez-Samartín, A | 1 |
| Leung, CK; Pang, CP; Zhong, YS | 1 |
| Aihara, M; Harada, C; Harada, T; Mitani, A; Nakamura, K; Namekata, K; Okumura, A; Quah, HM; Saeki, T; Tanaka, K; Yoshida, H | 1 |
| Schwartz, M; Yoles, E | 1 |
| Dreyer, EB; Gorla, MS; Vorwerk, CK | 1 |
| Dreyer, EB; Naskar, R; Vorwerk, CK | 1 |
| Dreyer, EB; Naskar, R | 1 |
5 review(s) available for glutamic acid and Cranial Nerve II Diseases
| Article | Year |
|---|---|
[Ocular vasospastic syndrome].
Topics: Apoptosis; Calcium Channel Blockers; Diagnosis, Differential; Endothelin-1; Excitatory Amino Acid Antagonists; Eye; Eye Diseases; Free Radicals; Glutamic Acid; Humans; Optic Nerve Diseases; Syndrome; Vascular Diseases | 2004 |
Glial cells and glaucomatous neuropathy.
Topics: Apoptosis; Extracellular Matrix Proteins; Glaucoma; Glutamic Acid; Humans; Neuroglia; Nitric Oxide Synthase; Optic Nerve; Optic Nerve Diseases; Retinal Ganglion Cells; Tumor Necrosis Factor-alpha | 2007 |
An experimental basis for implicating excitotoxicity in glaucomatous optic neuropathy.
Topics: Animals; Apoptosis; Enzyme Inhibitors; Glaucoma; Glutamic Acid; Humans; Intraocular Pressure; N-Methylaspartate; Neuroprotective Agents; Nitric Oxide Synthase; Optic Nerve Diseases; Retinal Ganglion Cells; Vitreous Body | 1999 |
Saving the nerve from glaucoma: memantine to caspaces.
Topics: Animals; Apoptosis; Caspase Inhibitors; Caspases; Excitatory Amino Acid Antagonists; Glaucoma; Glutamic Acid; Humans; Memantine; Nitric Oxide Synthase; Optic Nerve Diseases; Retinal Ganglion Cells | 1999 |
New horizons in neuroprotection.
Topics: Apoptosis; Cell Survival; Glaucoma, Open-Angle; Glutamic Acid; Humans; Nerve Growth Factors; Neuroprotective Agents; Nitric Oxide; Optic Nerve Diseases; Retinal Ganglion Cells | 2001 |
9 other study(ies) available for glutamic acid and Cranial Nerve II Diseases
| Article | Year |
|---|---|
A Small Natural Molecule S3 Protects Retinal Ganglion Cells and Promotes Parkin-Mediated Mitophagy against Excitotoxicity.
Topics: Glaucoma; Glutamic Acid; Humans; Mitochondrial Proteins; Mitophagy; Neuroprotective Agents; Neurotoxins; Optic Nerve Diseases; Retinal Ganglion Cells; Thiolester Hydrolases; Ubiquitin-Protein Ligases | 2022 |
Clinical and Histopathological Features of Gelsolin Amyloidosis Associated with a Novel
Topics: Adult; Aged; Amyloid Neuropathies, Familial; Amyloidosis; Amyloidosis, Familial; Corneal Diseases; Corneal Dystrophies, Hereditary; Exome; Family Health; Female; Fundus Oculi; Gelsolin; Genetic Association Studies; Glutamic Acid; Humans; Lysine; Male; Middle Aged; Mutation; Optic Nerve; Optic Nerve Diseases; Phenotype; Protein Folding; Tomography, Optical Coherence | 2021 |
Glaucoma as a neuropathy amenable to neuroprotection and immune manipulation.
Topics: Antigens; Calcium; Free Radicals; Glaucoma; Glutamic Acid; Humans; Intercellular Signaling Peptides and Proteins; Intraocular Pressure; Neuroprotective Agents; Optic Nerve Diseases; Oxidative Stress; Retinal Ganglion Cells; Risk Factors | 2008 |
Effects of acutely elevated hydrostatic pressure in a rat ex vivo retinal preparation.
Topics: Animals; Axons; Disease Models, Animal; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Fluorescent Antibody Technique, Indirect; Glial Fibrillary Acidic Protein; Glutamate-Ammonia Ligase; Glutamic Acid; Hydrostatic Pressure; Male; Optic Disk; Optic Nerve Diseases; Rats; Rats, Sprague-Dawley; Receptors, Glutamate; Retinal Diseases; Retinal Ganglion Cells | 2010 |
Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, I: Functional measures.
Topics: Administration, Oral; Animals; Cell Count; Chronic Disease; Disease Models, Animal; Electroretinography; Evoked Potentials, Visual; Excitatory Amino Acid Antagonists; Glaucoma; Glutamic Acid; Intraocular Pressure; Macaca fascicularis; Memantine; Ocular Hypertension; Optic Nerve Diseases; Retina; Retinal Ganglion Cells; Safety; Treatment Outcome; Vitreous Body | 2004 |
Vitreous glutamate concentration and axon loss in monkeys with experimental glaucoma.
Topics: Animals; Axons; Cell Count; Chromatography, High Pressure Liquid; Chronic Disease; Disease Models, Animal; Female; Glaucoma; Glutamic Acid; Intraocular Pressure; Laser Therapy; Macaca fascicularis; Macaca mulatta; Male; Optic Nerve; Optic Nerve Diseases; Trabecular Meshwork; Vitreous Body | 2005 |
Excitotoxic oligodendrocyte death and axonal damage induced by glutamate transporter inhibition.
Topics: Amino Acid Transport System X-AG; Animals; Animals, Newborn; Brain; Brain Damage, Chronic; Cell Death; Cells, Cultured; Demyelinating Diseases; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Excitatory Amino Acid Transporter 1; Excitatory Amino Acid Transporter 2; Glutamic Acid; Neurotoxins; Oligodendroglia; Oligodeoxyribonucleotides, Antisense; Optic Nerve Diseases; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, Kainic Acid; Wallerian Degeneration | 2005 |
The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma.
Topics: Amino Acid Transport System X-AG; Animals; Disease Models, Animal; Gene Expression Regulation; Glaucoma; Glutamic Acid; Intraocular Pressure; Mice; Mice, Inbred C57BL; Mice, Knockout; Mutation; Nerve Degeneration; Optic Nerve Diseases; Oxidative Stress; Retinal Ganglion Cells; Vision, Ocular | 2007 |
Elevation of intraocular glutamate levels in rats with partial lesion of the optic nerve.
Topics: Animals; Aqueous Humor; Aspartic Acid; Cell Death; Chromatography, High Pressure Liquid; Glutamic Acid; Male; Nerve Crush; Nerve Degeneration; Nerve Fibers; Optic Nerve Diseases; Optic Nerve Injuries; Rats; Rats, Sprague-Dawley; Retinal Ganglion Cells | 1998 |